General Information
Revision date
2011-11-30
Product name
Hyvisc Injection
Chemical name
Antibiotic
CAS No.
9067-32-7
1.2.1 Relevant identified uses
For the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis 2
Manufacturer Name
Transportation Emergency
Emergency telephone
1-800-424-9300, +1 703-527-3887
Icons in SDS
Company Information
company name
Transportation Emergency
Section 2
SECTION 2: Hazards identification
OSHA Regulatory Status Emergency Overview Physical State: Liquid Color: Clear Odor: No data available Low hazard for usual industrial or commercial handling by trained personnel. For use in horses only. Not for human use. Allergic reactions can occur.
Precautionary statements
Keep only in original container. Keep at a temperature between 2 - 7°C. Do not freeze. Accidental human injection can cause serious local reactions or anaphylactic reaction and systemic effects. Avoid contact with eyes, skin and clothing. Wash thoroughly with soap and water after handling. Wear suitable gloves and eye/face protection. Spills: Cover with absorbent or contain. Collect and incinerate. If swallowed, seek medical advice immediately and show this container or label. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Have the product container or label with you when calling a poison control center or doctor, or going for treatment. Keep out of reach of children. Keep away from food, drink, and animal feedstuffs.
Potential health effects
Inhalation: Not expected to be an inhalation hazard with prescribed use. Eye Contact: Not expected to be a hazard to the eye with prescribed use. Exposure to liquid in eye may cause eye irritation. Skin Contact: Not expected to be a hazard to the skin with prescribed use. May cause skin irritation. May cause skin sensitization by contact. Can cause hypersensitive reactions. Ingestion: Expected to be a low ingestion hazard. Ingestion may cause nausea and systemic effects. Injection: Swelling at injection site may occur.
Potential chronic health
Possible hypersensitization (development of abnormal sensitivity) Target Organ(s): Skin
Environmental hazards
No data available